4//SEC Filing
Seehra Jasbir 4
Accession 0001209191-20-024232
CIK 0001664710other
Filed
Apr 12, 8:00 PM ET
Accepted
Apr 13, 5:19 PM ET
Size
8.6 KB
Accession
0001209191-20-024232
Insider Transaction Report
Form 4
Seehra Jasbir
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Conversion
Series C Preferred Stock
2020-04-13−11,169→ 0 total→ Common Stock (11,169 underlying) - Conversion
Common Stock
2020-04-13+11,169→ 223,856 total - Purchase
Common Stock
2020-04-13$16.00/sh+20,000$320,000→ 243,856 total
Footnotes (1)
- [F1]Each share of Series C Preferred Stock converted into shares of Common Stock upon the closing of the Issuer's initial public offering, on a one-for-one basis, and had no expiration date.
Documents
Issuer
Keros Therapeutics, Inc.
CIK 0001664710
Entity typeother
Related Parties
1- filerCIK 0001732369
Filing Metadata
- Form type
- 4
- Filed
- Apr 12, 8:00 PM ET
- Accepted
- Apr 13, 5:19 PM ET
- Size
- 8.6 KB